R. Ducray

发表

Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators.

R. A. Norman, James S. Scott, A. Bailey, 2015, Journal of medicinal chemistry.

Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase.

A. Lau, B. Barlaam, S. Degorce, 2016, Journal of medicinal chemistry.

Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase.

J. Nissink, G. Walker, R. Ducray, 2011, Bioorganic & medicinal chemistry letters.

Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.

R. Ducray, J. Curwen, C. D. Jones, 2011, Bioorganic & medicinal chemistry letters.

A versatile route to 3-(pyrimidin-4-yl)-imidazo[1,2-a]pyridines and 3-(pyrimidin-4-yl)-pyrazolo[1,5-a]pyridines

G. L. Young, R. Ducray, M. Maudet, 2010 .

Two novel 1,2,4,5-tetrazines that participate in inverse electron demand Diels-Alder reactions with an unexpected regioselectivity.

D. Boger, R. Ducray, Akiyuki Hamasaki, 2006, The Journal of organic chemistry.

Total synthesis of (+/-)-FR66979.

R. Ducray, M. Ciufolini, 2002, Angewandte Chemie.

Tris(trifluoromethanesulfonyl)methide ("Triflide") Anion: Convenient Preparation, X-ray Crystal Structures, and Exceptional Catalytic Activity as a Counterion with Ytterbium(III) and Scandium(III).

Andrew J. P. White, David J. Williams, A. Barrett, 1999, The Journal of organic chemistry.

The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one).

Nichola L. Davies, B. Barlaam, S. Degorce, 2018, Journal of medicinal chemistry.

Inhibitors of the Tyrosine Kinase EphB4. Part 3. Identification of Non-benzodioxole-Based Kinase Inhibitors.

D. Cross, B. Barlaam, R. Ducray, 2011 .

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Ducray, 2008, Bioorganic & medicinal chemistry letters.

Novel 3‐Alkoxy‐1H‐pyrazolo[3,4‐d]pyrimidines as EGFR and erbB2 Receptor Tyrosine Kinase Inhibitors.

B. Barlaam, R. Ducray, P. Ballard, 2008 .

Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.

Peter Ballard, Jason G. Kettle, B. Barlaam, 2008, Bioorganic & medicinal chemistry letters.

Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R).

Scott Boyd, S. Degorce, R. Ducray, 2016, Journal of medicinal chemistry.

Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series.

D. Cross, B. Barlaam, R. Ducray, 2011, Bioorganic & medicinal chemistry letters.

Inhibitors of the tyrosine kinase EphB4. Part 3: identification of non-benzodioxole-based kinase inhibitors.

D. Cross, B. Barlaam, R. Ducray, 2010, Bioorganic & medicinal chemistry letters.

Lanthanoid Triflate and Triflide Catalyzed Atom Economic Nitration of Fluoroarenes.

A. Barrett, R. Ducray, F. J. Waller, 2000 .